polybutylene glycol/mdi copolymer은 임신 중 안전한가요?

Related ingredients

Frequently asked questions

polybutylene glycol/mdi copolymer은 임신 중 안전한가요?

No harmonised reproductive classification (ECHA Annex VI) or CIR/SCCS opinion for 'polybutylene glycol/MDI copolymer' was identified. Regulatory concerns for MDI relate mainly to sensitisation and acute toxicity; polymeric MDI products are generally considered distinct from monomeric MDI with much lower bioavailability. In absence of reproductive/toxicology data or harmonised H360/H361 classifications for this specific polymer, default scoring is 0. Sources consulted: ECHA Annex VI (harmonised CLP), PubChem (MDI hazard profile), ECHA registration dossiers/CosIng (no reproductive classification for polymer).

polybutylene glycol/mdi copolymer은 모유 수유 중 안전한가요?

Same rationale as for pregnancy: no specific reproductive or lactation hazard identified for the polymer. Potential risk would stem from residual monomer (MDI) which is primarily a local irritant/sensitiser; no evidence that the polymer itself transfers into milk or causes systemic reproductive toxicity. No CIR/SCCS or harmonised CLP reproductive flags for the polymer were found.

polybutylene glycol/mdi copolymer은 아기 피부에 안전한가요?

Hazard and mechanism remain 0 for the polymer (no reproductive/teratogenic evidence). Exposure score increased by +1 for infants because infant skin has higher permeability and surface area:weight, so if any low‑MW residual MDI/oligomers are present they could have measurable absorption. However, the intact high‑MW polymer itself is expected to have negligible dermal absorption. Key concern is residual free MDI rather than the polymer.

VeriMom은 polybutylene glycol/mdi copolymer을 어떻게 평가하나요?

VeriMom은 EU CosIng, ECHA 분류, PubMed 연구를 기반으로 polybutylene glycol/mdi copolymer을 100/100 (알려진 위험 없음)로 평가합니다.

임신 중 polybutylene glycol/mdi copolymer 대체 안전 성분은?

유사한 기능을 가진 알려진 위험이 없는 대체 성분 목록을 확인하세요.